Fort Sheridan Advisors LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1606666 HIGHLAND PARK, IL

Position in REGN

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$216,339

+$216 QoQ

Shares Held

280

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Fort Sheridan Advisors LLC holds $2,120,562 across 5 Biotechnology names. REGN ranks #4 (10.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,674	$747,507
2	MGTX	MeiraGTx Holdings plc	66,860	$579,007
3	ALNY	Alnylam Pharmaceuticals, Inc.	1,701	$562,809
4	REGN	Regeneron Pharmaceuticals, Inc. This page	280	$216,339
5	GERN	Geron Corp	10,000	$14,900

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$216,339	280	0.0%	Shares	Sole	2026-05-06
2025-12-31	$216,123	280	-5.1%	Shares	Sole	2026-02-10
2024-09-30	$310,115	295	0.0%	Shares	Sole	2024-11-14
2024-06-30	$310,053	295	+20.4%	Shares	Sole	2024-08-13
2024-03-31	$235,810	245	0.0%	Shares	Sole	2024-05-15
2023-12-31	$215,181	245	-16.9%	Shares	Sole	2024-02-14
2023-09-30	$242,773	295	0.0%	Shares	Sole	2023-11-08
2023-06-30	$211,969	295	0.0%	Shares	Sole	2023-08-01
2023-03-31	$242,392	295	0.0%	Shares	Sole	2023-05-12
2022-12-31	$212,839	295	0.0%	Shares	Sole	2023-02-15
2022-09-30	$203,216	295	0.0%	Shares	Sole	2022-11-09
2022-03-31	$206,033	295	-14.5%	Shares	Sole	2022-05-09
2021-09-30	$208,787	345	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.